Related Experiment Video

Updated: Apr 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

LDL-Cholesterol Lowering Therapies: An Update

Robert Humphrey1, Louise Bowman1

  • 1Clinical Trial Service Unit, Oxford Population Health, University of Oxford, OX3 7LF Oxford, UK.

British Journal of Hospital Medicine (London, England : 2005)
|April 29, 2026
PubMed

Insights

Lowering low-density lipoprotein-cholesterol (LDL-C) is key for preventing atherosclerotic cardiovascular disease (ASCVD). Combining statins with newer therapies like PCSK9 inhibitors offers enhanced LDL-C reduction for optimal cardiovascular risk management.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Genetics

Background:

  • Low-density lipoprotein-cholesterol (LDL-C) is a primary causal factor in atherosclerotic cardiovascular disease (ASCVD).
  • Extensive evidence supports LDL-C reduction as a cornerstone of cardiovascular risk mitigation.
  • Statins are the established first-line therapy for lowering LDL-C due to proven efficacy and safety.

Purpose of the Study:

  • To review the evolving landscape of LDL-C-lowering therapies.
  • To highlight the mechanisms, evidence base, and clinical implications of various agents.
  • To discuss the potential of combining established and novel therapies for ASCVD prevention.

Main Methods:

  • Literature review of genetic, epidemiological, and randomized controlled trial data.
  • Analysis of established LDL-C-lowering agents (statins, ezetimibe, bempedoic acid, PCSK9 inhibitors).
  • Exploration of emerging therapies including RNA-based treatments, oral small molecules, and gene editing.

Main Results:

  • Therapeutic options for LDL-C reduction have significantly expanded beyond statins.
  • Novel agents can be used alone or in combination with statins to achieve LDL-C targets.
  • Emerging RNA-based, small molecule, and gene-editing strategies promise greater LDL-C reduction.

Conclusions:

  • A "lower is better" approach is increasingly supported by evidence.
  • Combining existing and novel LDL-C-lowering therapies presents opportunities for optimizing ASCVD prevention.
  • Understanding the evolving therapeutic landscape is crucial for clinical practice.

Keywords:
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsLDL-cholesterolPCSK9 inhibitorsezetimibehypercholesterolemiasmall interfering RNA

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.4K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
840